Fulcrum Therapeutics Cut to Neutral From Overweight by Cantor Fitzgerald
Fulcrum Therapeutics Cut to Underperform From Neutral by B of A Securities
Interpublic Cut to Sell From Neutral by UBS
Micron Technology Cut to Underperform From Outperform by Exane BNP Paribas
Oncternal Therapeutics Cut to Hold From Buy by Brookline Capital
Oncternal Therapeutics Cut to Market Perform From Outperform by Northland Capital Markets
PotlatchDeltic Raised to Buy From Neutral by B of A Securities
Roku Raised to Outperform From Peer Perform by Wolfe Research
Simon Property Cut to Hold From Buy by Stifel
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
September 13, 2024 06:12 ET (10:12 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.